SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-21-008223
Filing Date
2021-01-27
Accepted
2021-01-27 17:02:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1 tm214304d1_s1.htm S-1 256459
2 EXHIBIT 5.1 tm214304d1_ex5-1.htm EX-5.1 8009
3 EXHIBIT 23.1 tm214304d1_ex23-1.htm EX-23.1 2671
4 GRAPHIC tm214304d1_ex5-1img001.jpg GRAPHIC 8044
5 GRAPHIC tm214304d1_s1img001.jpg GRAPHIC 12900
  Complete submission text file 0001104659-21-008223.txt   297318
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-252482 | Film No.: 21560704
SIC: 2836 Biological Products, (No Diagnostic Substances)